From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...

The tech giant is set to report earnings as AI spending faces scrutiny. Here's what to expect.

Faricimab demonstrated noninferior vision gains and improved anatomical outcomes among patients with diabetic macular edema ...

Boehringer Ingelheim’s lung disease drug nerandomilast has been successful in a Phase III study paving the way for the ...

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

Optiscan said the collected images would be used to assess real ... and progress planning for the upcoming clinical phase to follow over coming months. The company said the staged approach to ...

supports Phase I-IV trials of all sizes ... its operations while pushing the boundaries of innovation in clinical research. About Image Analysis Group (IAG) IAG is a leading imaging Clinical ...

Image: Adobe Stock. In a 36-month follow-up analysis from two phase 3 pivotal clinical trials, 70% of patients who underwent treatment with the iDose TR (travoprost intracameral implant ...

Charles River and Deciphex focus on advancing image management solutions, while developing novel AI tools for toxicologic pathology.